Clinical Trials Arena on MSN
Milestone begins Canadian enrolment in Phase III AFib-RVR trial
The Montreal Heart Institute enrolled Canada’s first participant as part of global recruitment of nearly 150 AFib-RVR ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that the Montreal ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative ...
Atrioventricular reentrant tachycardia (AVRT) is a rhythm problem in your heart that makes it beat too fast. It results from an extra connection between your upper and lower chambers. You might hear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results